Tracheal cuff leak in morbid obese patients intubated with a taperguard or a hi-lo cuffed endotracheal tube evaluated by bronchoscopy

2010 ◽  
Vol 27 ◽  
pp. 250 ◽  
Author(s):  
F. Van den Brande ◽  
J. Mulier ◽  
B. Dillemans
2020 ◽  
Vol 99 (6) ◽  
pp. 271-276

Introduction: Prevalence of obesity is 30 % in the Czech Republic and is expected to increase further in the future. This disease complicates surgical procedures but also the postoperative period. The aim of our paper is to present the surgical technique called hand-assisted laparoscopic nephrectomy (HALS), used in surgical management of kidney cancer in morbid obese patients with BMI >40 kg/m2. Methods: The basic cohort of seven patients with BMI >40 undergoing HALS nephrectomy was retrospectively evaluated. Demographic data were analyzed (age, gender, body weight, height, BMI and comorbidities). The perioperative course (surgery time, blood loss, ICU time, hospital stay and early complications), tumor characteristics (histology, TNM classification, tumor size, removed kidney size) and postoperative follow-up were evaluated. Results: The patient age was 38−67 years; the cohort included 2 females and 5 males, the body weight was 117−155 kg and the BMI was 40.3−501 kg/m2. Surgery time was 73−98 minutes, blood loss was 20−450 ml, and hospital stay was 5−7 days; incisional hernia occurred in one patient. Kidney cancer was confirmed in all cases, 48–110 mm in diameter, and the largest removed specimen size was 210×140×130 mm. One patient died just 9 months after the surgery because of metastatic disease; the tumor-free period in the other patients currently varies between 1 and 5 years. Conclusion: HALS nephrectomy seems to be a suitable and safe surgical technique in complicated patients like these morbid obese patients. HALS nephrectomy provides acceptable surgical and oncological results.


2020 ◽  
Vol 26 (1) ◽  
Author(s):  
Abdrabuh M. Abdrabuh

Abstract Background To assess Impact of weight on stone-free rate during percutaneous nephrolithotomy. Methods Hundred and twenty-three PNL procedures were done between January 2016 and July 2017. The patients were divided into four groups according to the World Health Organization (WHO) classification of body mass index (BMI): < 25 ((group 1, average)), 25–29.9 (group 2, overweight), 30–39.9 (group 3, obese), and ≥ 40 kg/m2 (group 4, morbidly obese). All groups were compared as regarding preoperative variables, intra-operative procedure and postoperative results. Results The non-obese groups were younger in age than obese and morbid obese groups (P = 0.005). The difference in BMI was statistically significant between non-obese and obese groups (P = 0.0001). Most of females gender were obese and morbid obese (P = 0.0001) and most of the obese patients had left-sided renal stone (P = 0.001). Most of overweight and obese groups had radiopaque stones (P = 0.02). There were no statistically significant differences between all groups as regarding co-morbidity, stone size, stone locations, and hydronephrosis grade. Operative time (P = 0.034), length of hospital stay (P value = 0.014) and fluoroscopy time (P = 0.0001) were statistically significant differences between all groups. Number of accesses, access site, postoperative hemoglobin drop, post- operative complications, fate of residual stones and stone-free rate were not statistically significant differences between all groups. BMI was correlated with mean fluoroscopy time and mean hospitalization duration in our study as the time of hospitalization and time of x-ray exposure increase with obesity. Conclusion PNL is a safe and effective procedure for obese patients. BMI do not predict clearance post PNL.


2016 ◽  
Vol 36 ◽  
pp. 173-177 ◽  
Author(s):  
James Schneider ◽  
Unami Mulale ◽  
Stephanie Yamout ◽  
Sharon Pollard ◽  
Peter Silver

1994 ◽  
Vol 81 (3) ◽  
pp. 790-791 ◽  
Author(s):  
Juraj Sprung ◽  
Denis L. Bourke ◽  
Padmini Thomas ◽  
Charles Harrison

2019 ◽  
Vol 47 (5) ◽  
pp. 387-391
Author(s):  
Lee C. Chang ◽  
◽  
Susan C. Lee ◽  
Andrew L. Ding ◽  
Suman Rajagopalan ◽  
...  

2021 ◽  
Author(s):  
Taskin Erkinuresin ◽  
Hakan Demirci ◽  
Haci Murat Cayci ◽  
Umut Eren Erdogdu ◽  
Ufuk Arslan

Sign in / Sign up

Export Citation Format

Share Document